Since it is acknowledged that activation of caspase-9 triggers caspase-3, Ojo and Olorunsogo [18] speculate that QUE administration would reduce excessive caspase-3 activity and thus down-regulate testicular death in diabetes. Here, CASP9 is linked to diabetes mellitus.